Biocartis Group N.V.

Biocartis Group N.V.verified

BCART.BR

Price:

$0.29

Market Cap:

$27.24M

Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reaction system that offers molecular information that allows treatment selection and treatment progress monitoring. The company offers Idylla BRAF, KRAS, MSI, EGFR, and NRAS-BRAF mutation tests; and Idylla SARS-CoV-2/Flu/RSV panels and SARS-CoV-2 tests, as well as SeptiCyte RAPID, a rapid host-response test. It also provides research products, including MSI, KRAS, BRAF, ctEGFR, NRAS-BRAF-EGFR S492R, ...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2015-04-27

Stock Exchange

BRU

Ticker

BCART.BR

The Enterprise Value as of December 2025 (TTM) for Biocartis Group N.V. (BCART.BR) is 124.67M

According to Biocartis Group N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 124.67M. This represents a change of -43.00% compared to the average of 218.70M of the last 4 quarters.

Biocartis Group N.V. (BCART.BR) Historical Enterprise Value (quarterly & annually)

How has BCART.BR Enterprise Value performed in the past?

The mean historical Enterprise Value of Biocartis Group N.V. over the last ten years is 440.33M. The current 124.67M Enterprise Value has changed 2.73% with respect to the historical average. Over the past ten years (40 quarters), BCART.BR's Enterprise Value was at its highest in in the December 2014 quarter at 620.75M. The Enterprise Value was at its lowest in in the January 2012 quarter at 0.

Quarterly (TTM)
Annual

Average

440.33M

Median

464.92M

Minimum

129.40M

Maximum

620.75M

Biocartis Group N.V. (BCART.BR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biocartis Group N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 17.85%

Maximum Annual Enterprise Value = 620.75M

Minimum Annual Increase = -61.98%

Minimum Annual Enterprise Value = 129.40M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022129.40M-61.98%
2021340.33M3.17%
2020329.87M-3.90%
2019343.26M-38.27%
2018556.10M1.47%
2017548.05M17.85%
2016465.03M0.05%
2015464.81M-25.12%
2014620.75M2.48%
2013605.73M3.12%

Biocartis Group N.V. (BCART.BR) Average Enterprise Value

How has BCART.BR Enterprise Value performed in the past?

The current Enterprise Value of Biocartis Group N.V. (BCART.BR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

266.53M

5-year avg

339.79M

10-year avg

440.33M

Biocartis Group N.V. (BCART.BR) Enterprise Value vs. Peers

How is BCART.BR’s Enterprise Value compared to its peers?

Biocartis Group N.V.’s Enterprise Value is less than Mithra Pharmaceuticals S.A. (211.34M), less than MDxHealth S.A. (220.22M), less than Ontex Group N.V. (1.01B), less than argenx SE (52.09B), greater than Celyad Oncology S.A. (8.32M),

CompanyEnterprise ValueMarket cap
211.34M$14.45M
220.22M$85.63M
1.01B$405.47M
52.09B$46.10B
8.32M$8.28M

Build a custom stock screener for Biocartis Group N.V. (BCART.BR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocartis Group N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biocartis Group N.V. (BCART.BR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biocartis Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Biocartis Group N.V.'s Enterprise Value?

What is the highest Enterprise Value for Biocartis Group N.V. (BCART.BR)?

What is the 3-year average Enterprise Value for Biocartis Group N.V. (BCART.BR)?

What is the 5-year average Enterprise Value for Biocartis Group N.V. (BCART.BR)?

How does the current Enterprise Value for Biocartis Group N.V. (BCART.BR) compare to its historical average?